Actively Recruiting
Quantitative Analysis of Bisphosphonate Scintigraphy to Track Amyloid Burden in Patients with Transthyretin Cardiac Amyloidosis Treated with Tafamidis
Led by GCS Ramsay Santé pour l'Enseignement et la Recherche · Updated on 2026-08-20
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Cardiac amyloidosis is a condition where abnormal amyloid protein deposits build up in the heart, leading to restrictive cardiomyopathy with preserved ejection fraction. This study focuses on transthyretin-related cardiac amyloidosis ATTR, which can be diagnosed using various imaging methods including planar bone scintigraphy. Researchers are evaluating a new quantitative analysis method using bisphosphonate scintigraphy to better measure amyloid burden over time, as current semi-quantitative methods have limitations in assessing disease progression and patient prognosis. Participants in this study will undergo bone scintigraphy, a diagnostic imaging procedure that uses bisphosphonate to detect amyloid deposits in the heart. The study is designed as a single group observational evaluation of patients diagnosed with transthyretin cardiac amyloidosis and treated with tafamidis. This method aims to provide a quantitative measurement called SUVmax, which will be tracked every 6 months to monitor disease evolution. Throughout the study, participants will have their amyloid burden measured by SUVmax using bisphosphonate scintigraphy at regular 6-month intervals. This imaging evaluation will help assess changes in amyloid deposits over time. The study includes patients aged 18 and older who have signed consent and have confirmed ATTR diagnosis. The primary outcome is the measurement of SUVmax at 6 months, with the study completion expected by the end of 2026.
CONDITIONS
Brief Title
Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy
Research Team
F
Frederic MOUQUET
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here